897 related articles for article (PubMed ID: 23777885)
1. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
2. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
3. The application of aptamers in cancer research: an up-to-date review.
Hu M; Zhang K
Future Oncol; 2013 Mar; 9(3):369-76. PubMed ID: 23469972
[TBL] [Abstract][Full Text] [Related]
4. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
Wang XL; Wang QQ; Song HF
Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
[TBL] [Abstract][Full Text] [Related]
6. Current progress on aptamer-targeted oligonucleotide therapeutics.
Dassie JP; Giangrande PH
Ther Deliv; 2013 Dec; 4(12):1527-46. PubMed ID: 24304250
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
Zhu H; Li J; Zhang XB; Ye M; Tan W
ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
[TBL] [Abstract][Full Text] [Related]
8. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
9. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
Kim M; Kim DM; Kim KS; Jung W; Kim DE
Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
[TBL] [Abstract][Full Text] [Related]
10. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
11. Advances in aptamer-mediated targeted delivery system for cancer treatment.
He S; Du Y; Tao H; Duan H
Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
[TBL] [Abstract][Full Text] [Related]
12. Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.
Reinemann C; Strehlitz B
Swiss Med Wkly; 2014 Jan; 144():w13908. PubMed ID: 24395443
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology and aptamers: applications in drug delivery.
Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
[TBL] [Abstract][Full Text] [Related]
14. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery.
Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM
Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771
[TBL] [Abstract][Full Text] [Related]
15. Multivalent comb-type aptamer-siRNA conjugates for efficient and selective intracellular delivery.
Yoo H; Jung H; Kim SA; Mok H
Chem Commun (Camb); 2014 Jun; 50(51):6765-7. PubMed ID: 24830507
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
[TBL] [Abstract][Full Text] [Related]
17. Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles.
Zununi Vahed S; Fathi N; Samiei M; Maleki Dizaj S; Sharifi S
J Drug Target; 2019 Mar; 27(3):292-299. PubMed ID: 29929413
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted drug delivery with aptamers.
Zhang Y; Hong H; Cai W
Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687
[TBL] [Abstract][Full Text] [Related]
19. Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery.
Gilboa E; Berezhnoy A; Schrand B
Cancer Immunol Res; 2015 Nov; 3(11):1195-200. PubMed ID: 26541880
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]